iCamuno starts with induced pluripotent stem cells (iPSCs) and uses cutting-edge technologies such as gene editing, and algorithm-driven cellular differentiation to empower cells. Guided by the philosophy of “demand-oriented, patient-centered”, we are changing the face of tumor immunotherapy and regenerative medicine, providing patients with universal, effective, and affordable cell therapies.
